Hong Kong-based pharmaceutical company Aptorum Group Limited is seeking to raise up to US$30 million in an initial public offering of its class A ordinary shares in the U.S., according to a statement released by the company yesterday.
Hong Kong-Based Pharma Aptorum Seeks To Raise Up To $30M In US IPO appeared first on China Money Network.